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Abstract Sulfatide induces leukocyte activation, which is 
thought to be mediated via L-selectin. Here we demonstrate 
that lymphocytes express a receptor for sulfatide distinct from 
L-selectin and that this receptor is involved in sulfatide-induced 
cell activation. While cell surface L-selectin expression was 
abolished by phorbol 12-myristate 13-acetate (PMA), lympho-
cytes retained the ability to bind sulfatide in liquid phase as well 
as in immobilized solid phase. The novel sulfatide receptor 
obtained from PMA-treated lymphocytes showed a molecular 
size of 65 kDa. Stimulation through this receptor triggered 
cytosolic free Ca2+ elevation and intercellular aggregation. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Sulfatide, 3-sulfated galactosyl-ceramide, is distributed 
widely in the brain, kidney, spleen, gastrointestinal tract, 
granulocytes, platelets, some cancer cells and serum [1-3]. 
Sulfatide has anticoagulant activity [4], but its biological sig-
nificance remains unknown. Sulfatide is also involved in cell 
adhesion processes necessary for infection by some bacteria, 
malaria and viruses [5-8]. For instance, Helicobacter pylori 
apparently uses sulfatide on gastric mucosa as an adhesion 
receptor for the establishment of infection [5]. Other studies 
have reported the interaction of sulfatide with extracellular 
matrix proteins such as thrombospondin and laminin, which 
may play a role in the regulation of cell adhesion and spread-
ing (reviewed in [2]). Recently, sulfatide has received much 
attention, since it was shown to bind to L- and P-selectins 
[3,9], and its administration prevented leukocyte accumulation 
and tissue injury in some models of inflammatory diseases 
[10,11]. 
Sulfatide induces signaling and metabolic changes in neu-
trophils, which are thought to be mediated via L-selectin [12]. 
However, the following observations raise the question of 
whether L-selectin is the sole functional receptor for sulfatide 
or not. In a series of preliminary experiments, we observed 
that PMA-treated lymphocytes and neutrophils lacking sur-
face expression of L-selectin adhered well to immobilized sul-
fatide (H. Kawashima, unpublished observation). Laudanna 
et al. [13] showed that fucoidan (a sulfated polysaccharide 
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from marine algae rich in L-fucose) and PPME (mannose-6-
phosphate rich polyphosphomann ester from yeast), both of 
which are reactive with L-selectin, did not induce Ca2+ influx 
signal in neutrophils, although sulfatide did. In the study re-
ported by Waddell et al. [12], sulfatide induced larger in-
creases in tyrosine phosphorylation and MAP kinase activity 
than did ligation of L-selectin with the monoclonal antibodies 
(mAb) DREG 56 or DREG 200. Together, these observations 
suggest that a novel sulfatide receptor distinct from L-selectin 
is expressed on the leukocyte surface. 
In the present study, we used phorbol 12-myristate 13-ace-
tate (PMA) to abrogate cell surface L-selectin and studied the 
capacity of PMA-treated cells to bind sulfatide. We report 
that a sulfatide receptor other than L-selectin, with a molec-
ular mass of 65 kDa, is expressed on lymphocytes. This mol-
ecule can mediate increases in sulfatide-triggered cytosolic free 
Ca2+ and lymphocyte aggregation, and may play an impor-
tant role in lymphocyte activation and recruitment into spe-
cific tissues. 
2. Materials and methods 
2.1. Animals 
Eight- to 12-week-old male specific-pathogen-free Wistar rats were 
provided by the Shionogi Pharmaceutical Co., Osaka, Japan, and 
used according to the guidelines of the Animal Ethics Committee of 
Osaka University Medical School. 
2.2. Antibodies and reagents 
HRL2 and HRL3 are hamster anti-rat L-selectin mAbs (both IgG) 
prepared in our laboratory [14]. HRL2 is a non-blocking mAb, di-
rected to the complement-binding protein homology domain [15], 
whereas HRL3 is a blocking mAb directed to the lectin domain of 
L-selectin. GS5 [16], a mouse anti-sulfatide mAb (IgM), was used as 
culture supernatant. FITC-labeled goat anti-hamster IgG was pur-
chased from Organon Teknika Co. (Durham, NC). FITC-labeled 
donkey anti-mouse IgM was obtained from Jackson ImmunoResearch 
Laboratories, Inc. (West Grove, PA). FITC-labeled goat anti-mouse 
Ig (IgG+IgM) was a product of Southern Biotechnology Associates, 
Inc. (Birmingham, AL). PMA, A23187, and sulfatide were all ob-
tained from Sigma (St. Louis, MO). Galactosylceramide was from 
Funakoshi (Tokyo, Japan). Fluo 3-AM and 2',7'-bis-(2-carboxyeth-
yl)-5-carboxyfluorescein acetoxymethylester (BCECF-AM) were from 
Dojindo (Osaka, Japan). 
2.3. Flow cytometry 
Lymphocytes were either unstimulated or stimulated with 50 ng/ml 
PMA at 37°C for 5, 10, and 30 min. Cells were washed twice with 
PBS, incubated with 300 ug/ml of sulfatide (dissolved in DMSO at 
50 mg/ml and diluted with PBS) on icebath for 30 min. Then cells 
were again washed twice with PBS. Cell-bound sulfatide was detected 
by GS5, using a 1:50 dilution of culture supernatant and FITC-
labeled donkey anti-mouse IgM. L-Selectin expression was detected 
by incubating the cells with HRL3 at 10 ng/ml for 30 min on ice, and 
then washed twice with washing buffer (PBS containing 0.1% BSA 
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and 0.05% sodium azide). Cells were then stained with FITC-labeled 
anti-hamster IgG at 5 |ig/ml for 30 min on ice. Finally the cells were 
washed twice and resuspended in PBS for flow cytometric analysis in 
an Epics XL flow cytometer (Coulter Electronics, Hialeah, FL). 
2.4. Adhesion assay 
Sulfatide dissolved in methanol was immobilized on 96-well ELISA 
plates (SUMILON, H type, Japan) by drying at 37°C for 1.5 h. Plates 
were then blocked with 3% bovine serum albumin (BSA) in phos-
phate-buffered saline (PBS) overnight at 4°C. The wells were washed 
three times with 0.05% Tween 20 in PBS before cells were plated. 
Lymphocytes were isolated from mesenteric lymph nodes (MLN) of 
male Wistar rats. After washing twice with RPMI 1640 medium, cells 
were labeled for 40 min at 37°C with BCECF-AM at a final concen-
tration of 5 (J.M. A portion of cells was exposed to 50 ng/ml PMA in 
the last 10 min of the labeling process. The cells were then washed 
once with RPMI medium containing 10% FCS and twice with RPMI 
only. Aliquots of the cells were preincubated with 100-300 |ig/ml 
sulfatide for 30 min on icebath, washed and resuspended in RPMI 
at 5-8 X106 cells/ml. In the next step, 50 JJ.1 of cell suspension was 
added in quadruplicate to wells coated with sulfatide. After 40 min 
incubation at 7°C, the wells were filled with RPMI medium and sealed 
with parafilm. The plates were inverted for 40 min at 7°C to allow 
non-adherent cells to detach from the bottom surface of the wells, 
after which the medium containing unbound cells was removed by 
suction. The remaining bound cells were lysed in 50 |xl of 1% 
NP-40, and fluorescence intensity was read in a Fluoroskan II micro-
plate fiuorometer (Labsystem, Tokyo, Japan) at an excitation wave-
length of 485 nm and emission wavelength of 538 nm. The results are 
expressed as mean ± S.D. of quadruplicate determinations. 
2.5. Measurement of cytosolic free calcium changes 
Lymphocytes suspended in RPMI were incubated with fluo 3-AM 
(final concentration of 2.5 (iM) for 40 min at 37°C. Part of the cells 
was treated with 50 ng/ml PMA in the final 10 min of incubation. 
Cells were washed and resuspended in Hanks' balanced salt solution 
(HBSS) with 10 mM HEPES. Fluorescence was measured in a spec-
trophotometer (model F3000, Hitachi, Tokyo, Japan), equipped with 
a magnetic stirrer and a thermostatic cuvette chamber. Excitation was 
set at 488 nm and emission at 535 nm. After a stable baseline was 
obtained, DMSO was added to assess the effect of solvent control. 
The cells were then stimulated with 400 (ig/ml sulfatide. Calcium 
ionophore A23187 (5 |iM) was finally applied to assess the reliability 
of the cellular responses. 
a horseradish peroxidase-conjugated avidin-biotin complex (ABC kit, 
Vector, Burlingame, CA) and enhanced chemiluminescence (ECL, 
Amersham) as described in the attached specifications. 
3. Results 
3.1. Lymphocytes express a sulfatide receptor distinct from 
L-selectin 
PMA-treated lymphocytes expressed no surface L-selectin 
but retained the ability to bind sulfatide, although levels of 
sulfatide binding were obviously decreased as compared to 
those by control lymphocytes (Fig. 1). The net decrease is 
probably due to the shedding of L-selectin that also binds 
sulfatide [9]. Sulfatide binding to lymphocytes devoid of L-
selectin expression was independent of divalent cations (data 
not shown), and increased significantly by prolonging the in-
cubation time with P M A . The L-selectin-independent binding 
of sulfatide by lymphocytes was further confirmed by cell 
adhesion to plastic-immobilized sulfatide (Fig. 2). P M A -
treated lymphocytes lacking L-selectin expression adhered 
well to sulfatide, albeit with slightly lower efficiency than 
that of untreated cells (Fig. 2A). The adhesive interaction 
was apparently specific, because the adhesion did not occur 
to immobilized non-sulfated analogous glycolipid, galactosyl-
ceramide. In addition, the adhesion correlated well with the 
quantity of immobilized sulfatide, and did not increase further 
when immobilized sulfatide was present at over 1 |xg per well 
(data not shown). Furthermore, preincubation of cells with 
soluble sulfatide dose-dependently decreased cell adhesion 
(Fig. 2B). These results suggested that sulfatide binds to a 
receptor(s) distinct from L-selectin. 
3.2. Sulfatide induces a rapid increase in intracellular 
Ca2+ concentration and lymphocyte aggregation via 
L-selectin-dependent and -independent pathways 
To examine whether the sulfatide receptor(s) can transduce 
2.6. Aggregation assay 
Lymphocytes treated with or without PMA (50 ng/ml, 37°C, 10 min) 
were resuspended at 5X106 cells/ml in RPMI medium containing 10% 
FCS. Next, 100 \i\ of cells were added to duplicate wells of 96-well 
culture plates (IWAKI, Japan). WT.l, mouse anti-rat LFA-1 mAb 
[17], was added to PMA-treated lymphocytes at 20 ng/ml. Sulfatide 
(300 ng/ml) and HRL3 (1 |ig/ml) were added to control and PMA-
treated cells respectively. The plates were incubated at 37°C for 2 h. 
Photographs were taken under a phase contrast microscope (Olym-
pus, Japan). 
2.7. Affinity purification of sulfatide binding protein 
Sulfatide was hydrophobically conjugated to octyl-Sepharose 
CL-4B (Pharmacia, Uppsala, Sweden) as reported previously [18], 
To block non-specific binding, the beads were incubated with 1% 
BSA in PBS for 1 h at room temperature, washed with PBS and 
packed into columns. MLN lymphocytes pretreated with 50 ng/ml 
PMA for 10 min at 37°C were surface-biotinylated with 50 |ig/ml 
NHS-LC-biotin (Pierce, IL) and lysed with 0.5% NP-40 in PBS sup-
plemented with 1 mM PMSF. The cell lysates were applied first to a 
non-conjugated octyl-Sepharose column for preclearance. The pass-
through fraction was subsequently applied to a sulfatide-bound octyl-
Sepharose column. The column was washed consecutively with PBS, 
1 M NaCl in PBS and 3 M NaSCN in PBS as described by Hirabaya-
shi et al. [17] and Mohan et al. [19]. The NaSCN eluate was dialyzed 
against PBS overnight, then precipitated with octyl-Sepharose beads 
conjugated with galactosylceramide. The supernatant was finally pre-
cipitated with sulfatide-conjugated octyl-Sepharose. Precipitated pro-
teins were eluted in SDS sample buffer, separated by SDS-PAGE, 
transferred to IPVH membrane (Millipore, Japan), and detected by 
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Fig. 1. PMA-treated lymphocytes lack surface L-selectin but retain 
the ability to bind sulfatide. Lymphocytes were either untreated or 
treated with 50 ng/ml PMA at 37°C for 5, 10, and 30 min. Cells 
were washed, incubated with 300 u,g/ml of sulfatide for 30 min on 
ice. Then cell-bound sulfatide was detected by GS5 and FITC-la-
beled donkey anti-mouse IgM in a flow cytometer. L-selectin expres-
sion was detected by HRL3 and FITC-labeled goat anti-hamster 
IgG. The dashed lines represent the background level obtained with 
FITC-labeled secondary antibodies only. 
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Fig. 2. PMA-treated lymphocytes adhere to immobilized sulfatide. 
A: PMA-treated lymphocytes showed reduced but significant adher-
ence to sulfatide. BCECF-AM-labeled lymphocytes were untreated 
or treated with 50 ng/ml of PMA for 10 min at 37°C. The cells 
were washed, resuspended in RPMI + 10% FCS, and subsequently 
applied to an ELISA plate coated with sulfatide. After incubation 
at 7°C for 40 min, unbound cells were removed by inverting the 
plates. Bound cells were lysed with 1% NP-40, and the fluorescence 
intensity was read in a microplate fluorometer. Open square and tri-
angle represent untreated and PMA-treated cell adhesion to immo-
bilized galactosylceramide, respectively. B: Lymphocyte adhesion to 
sulfatide was inhibited by preincubating cells with sulfatide. Ali-
quots of BCECF-AM-labeled cells, untreated or treated with PMA, 
were preincubated with sulfatide on ice for 30 min, washed, resus-
pended in RPMI+10% FCS, and then loaded onto plates adsorbed 
with sulfatide (1 ug/well). Representative data from four independ-
ent experiments are expressed as mean ± S.D. of quadruplicate wells. 
signals, we investigated the effects of sulfatide on intracellular 
Ca2+ concentration and cell aggregation. Sulfatide induced a 
rapid and sustained increase of cytosolic Ca2+ concentration 
in control lymphocytes (Fig. 3). This response was also in-
duced in PMA-treated lymphocytes lacking L-selectin expres-
sion, although its magnitude and duration was significantly 
less than control cells. In addition, HRL3, a mAb reactive 
with the ligand binding domain of L-selectin, induced aggre-
gation of control lymphocytes but not PMA-treated cells. 
Sulfatide induced homotypic aggregation of control, as well 
as PMA-treated lymphocytes (Fig. 4). The aggregation was 
more prominent in control cells than in PMA-treated cells 
lacking L-selectin. These results suggest that both L-selectin 
and the non-L-selectin type sulfatide receptor can deliver sig-
nals for Ca2+ elevation and cell aggregation on their own, and 
that they cooperate in sulfatide-induced changes of normal 
lymphocytes. 
3.3. The new sulfatide receptor is a 65 kDa protein 
In order to identify the non-L-selectin type binding protein 
for sulfatide on lymphocytes, lysates of PMA-treated and sur-
face-biotinylated lymphocytes were applied to an affinity col-
umn loaded with sulfatide-conjugated octyl-Sepharose CL-4B. 
After washing, the bound materials were eluted with 3 M 
NaSCN, dialyzed and then precipitated consecutively with 
control * 
PMA 
Fig. 3. Sulfatide triggers increases of cytoplasmic free Ca2+ through 
L-selectin-dependent and -independent pathways. Lymphocytes in 
RPMI (107 cells/ml) were labeled with 2.5 uM of fluo 3-AM at 
37°C for 30 min. The cells were either untreated or treated with 
50 ng/ml PMA in the final 10 min of the labeling process. Cells 
were washed three times with HBSS, and finally resuspended at 
2X106 cells/ml in HBSS supplemented with 10 mM HEPES. 
Changes in Ca2+ concentration were monitored with a Hitachi 
F-3000 fluorescence spectrophotometer. 
galactosylceramide-conjugated octyl-Sepharose and sulfatide-
conjugated octyl-Sepharose. The precipitates obtained by the 
use of sulfatide-conjugated Sepharose yielded a reproducible, 
prominent band of 65 kDa in SDS-PAGE analysis under re-
ducing conditions (Fig. 5, lane 2). The band was absent in the 
precipitate obtained with galactosylceramide-conjugated oc-
tyl-Sepharose (lane 1), and disappeared when the NaSCN 
eluate was incubated with sulfatide prior to precipitation 
(data not shown). 
4. Discussion 
In this study, we have demonstrated for the first time that a 
sulfatide binding site distinct from L-selectin is expressed on 
lymphocytes and is involved in sulfatide-induced lymphocyte 
activation. We tentatively call this binding site a receptor for 
sulfatide or sulfatide receptor, since it specifically bound sul-
fatide in liquid phase as well as in solid phase in a saturable 
manner. In sharp contrast to L-selectin, which is sensitive to 
proteolytic cleavage by PMA-activatable protease [20,21], the 
sulfatide receptor appears to be resistant to PMA-induced 
HRL3 
PMA 
mmms 
Fig. 4. Sulfatide induces homotypic aggregation of lymphocytes 
through L-selectin-dependent and -independent pathways. Control 
and PMA-treated (50 ng/ml, 37°C, 10 min) lymphocytes were 
washed and resuspended in RPMI+10% FCS at 5X106 cells/ml. 
100 |xl of cells were added to each well of a 96-well culture plate. 
Cells were stimulated with sulfatide (300 ng/ml) or HRL3 (1 ng/ml) 
at 37°C for 2 h. Photographs were taken under a phase-contrast mi-
croscope (original magnification X200). 
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Fig. 5. The sulfatide receptor has an MY of 65 kDa. Lysates of 
PMA-treated and biotinylated lymphocytes were first precleared by 
an octyl-Sepharose CL-4B column. The pass-through solution was 
then loaded on a column with sulfatide-bound octyl-Sepharose. 
After washing the column with PBS and 1 M NaCl, the bound pro-
teins were eluted with 3 M NaSCN, dialyzed and then precipitated 
sequentially with galactosylceramide-conjugated Sepharose and sul-
fatide-conjugated octyl-Sepharose. The precipitates were eluted in 
SDS sample buffer, separated by SDS-PAGE under reducing condi-
tions and blotted onto an IPVH membrane. Biotinylated proteins 
were detected by using an ABC kit and ECL. Lanes 1 and 2 repre-
sent precipitates with galactosylceramide-conjugated Sepharose and 
sulfatide-conjugated Sepharose, respectively. 
shedding. PMA-treated lymphocytes adhered well to immobi-
lized sulfatide, although adhesion was less efficient than that 
of untreated cells. The non-L-selectin-mediated adhesion to 
sulfatide is unlikely to be due to a non-specific hydrophobic 
interaction, because adhesion did not occur to a desulfated 
analogous glycolipid, galactosylceramide, and was blocked 
by preincubation of cells with sulfatide. 
Since sulfatide is known to bind to L- and P-selectin [12,18], 
the effects of sulfatide on leukocytes have been generally con-
sidered to be mediated by selectins. Sulfatide is expressed not 
only in some hemopoietic cells (granulocytes, platelets and 
myeloid tumor cells) but also in non-vascular cells and tissues. 
If extravascular sulfatide serves as an adhesion ligand for 
leukocytes, L-selectin would not be the cognate receptor, since 
leukocytes recruited into tissues express extremely low levels, 
if any, of L-selectin [22]. This notion prompted us to inves-
tigate the existence of a sulfatide receptor other than L-selec-
tin. A number of previous observations are also consistent 
with the presence of a non-L-selectin type sulfatide receptor. 
For example, in the Stamper-Woodruff assay, mouse lympho-
cytes adhered to the myelinated regions of the central nervous 
system rich in sulfatide. Lymphocyte adherence was only par-
tially inhibited (~30%) by MEL-14, a blocking mAb to 
mouse L-selectin [23]. In vitro studies with human neutrophils 
showed that sulfatide stimulation induced more prominent 
tyrosine phosphorylation, MAP kinase activation and super-
oxide production than did stimulation of L-selectin alone with 
mAbs [12,24]. In this study, we prepared surface-biotinylated 
lysates of PMA-treated lymphocytes lacking L-selectin expres-
sion and isolated a protein of ~ 6 5 kDa by affinity column 
chromatography and precipitation with sulfatide-conjugated 
octyl-Sepharose beads. The prominent band of 65 kDa was 
not observed when galactosylceramide-conjugated beads were 
used or cell lysates were preincubated with sulfatide, indicat-
ing that the 65 kDa protein is a specific molecule for sulfatide 
binding. We also observed strong and constitutive expression 
of a 65 kDa sulfatide binding-protein in a L-selectin-negative 
lymphoma cell line (Z. Ding et al., manuscript in prepara-
313 
tion). We are currently making attempts to isolate this protein 
to homogeneity for N-terminal amino acid sequencing. 
To examine the signaling function and physiological signifi-
cance of this new sulfatide receptor, we investigated whether 
sulfatide induces any changes in lymphocytes. Sulfatide in-
duced a rapid and sustained elevation of intracellular free 
Ca2+ concentration in normal lymphocytes. The response 
was moderately decreased in magnitude and duration in 
PMA-treated lymphocytes. This may be because the sulfatide 
receptor confers additive or synergistic activation signals to 
the cells along with L-selectin-mediated signal(s). In support 
of this argument, sulfatide-induced aggregation in normal 
lymphocytes was more intense than in PMA-treated L-selec-
tin-negative lymphocytes. The mechanism for homotypic lym-
phocyte aggregation triggered by sulfatide stimulation is not 
clear. Antibodies to LFA-1, CD44, and oc4 integrins did not 
block sulfatide-induced cell aggregation, indicating that these 
adhesion molecules are not important in this phenomenon 
(data not shown). Passive crosslinking of receptors on sepa-
rate cells by sulfatide is apparently not responsible either, 
because aggregate formation did not occur at 4°C and re-
quired metabolic energy as well as an intact cytoskeleton 
(Z. Ding et al., manuscript in preparation). 
In summary, the current study demonstrates for the first 
time the expression of a sulfatide receptor of 65 kDa on lym-
phocytes. This receptor is distinguishable from L-selectin by 
showing resistance to PMA-induced shedding. The new sulfa-
tide receptor apparently mediates intracellular Ca2+ changes 
and intercellular aggregation, suggesting its potential role in 
activation and functional changes of lymphocytes during in-
flammation. 
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